Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. Bullish option flow detected in ...

Thus, it is worth knowing the facts that could determine the stock's prospects. Bullish option flow detected in Crispr Therapeutics (CRSP) with 2,899 calls trading, 1.4x expected, and implied vol ...

VTV's blended value approach, attractive dividend yield, and lower volatility make it a strong core holding amid economic ...

Small-cap ETFs give you a way to buy the small-cap “haystack” rather than search through it for the high performers.

VB has shown strong growth prospects, attractive valuation, and technicals have stabilized after a difficult period. Click to ...

Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond ...

What does the future hold for Samsung? Read Benzinga's stock price prediction to learn more. Samsung's stock has experienced significant volatility over the past year, with a decrease of over 30% ...

Vanguard's ascension to becoming the world's 2nd largest asset manager after BlackRock has been built on the success of its ...

The share price is still 11.6% lower year to date, as well as down 22.9% since its 52-week high on Dec. 17, 2024. Tesla stock has gained 101.9% over the past year, leaving plenty of investors ...